.infobox .infobox-protein
{
float: right;
width: 300px;
padding: 10px;
background: #f8f9fa;
border: 1px solid #ddd;
border-radius: 4px;
margin: 10px;
}
.infobox .infobox-protein th
{
background: #28a745;
color: white;
padding: 8px;
}
.infobox .infobox-protein td
{
padding: 6px;
}
FBXO7 (F-Box Protein 7) is a substrate recognition component of the SCF E3 ubiquitin ligase complex with important roles in mitochondrial quality control. This page covers the structure, function, and disease relevance of FBXO7 in neurodegenerative processes.
FBXO7 is a member of the F-box protein family that serves as a substrate recognition component of the SCF (Skp1-Cul1-F-box) E3 ubiquitin ligase complex. The protein contains an N-terminal F-box domain that recruits the SCF complex, followed by a C-terminal substrate-binding region. FBXO7 plays critical roles in mitochondrial dynamics, mitophagy, and regulation of the PINK1-Parkin pathway.
FBXO7 contains an N-terminal F-box domain that recruits the SCF complex, followed by a C-terminal substrate-binding region. The protein can form homodimers and interacts with various partners through multiple domains.
FBXO7 is a substrate recognition component of the SCF (Skp1-Cul1-F-box) E3 ubiquitin ligase complex. It targets proteins for ubiquitination and degradation. FBXO7 plays roles in mitochondrial dynamics, mitophagy, and regulation of the PINK1-Parkin pathway. It also interacts with the transcription factor C/EBPβ.
FBXO7 mutations cause PARK15 (parkinsonian-pyramidal syndrome), characterized by early-onset parkinsonism with pyramidal signs. FBXO7 deficiency impairs mitophagy, leading to accumulation of damaged mitochondria and neuronal death. The protein is also implicated in ALS and FTD.
No specific therapies target FBXO7. Strategies to enhance mitophagy and mitochondrial function may be beneficial. Small molecules that activate the PINK1-Parkin pathway are being investigated. Gene therapy to restore FBXO7 function is in preclinical development.
The study of Fbxo7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.